Today’s News: Revolutionary Genome Sequencing, Vaccine Debates, and russian Disinformation
September 19, 2025 – Good morning. here’s a rundown of the most critically important stories shaping our world today, from a breakthrough in genetic medicine to concerning trends in disinformation and political polarization.
Genome Sequencing Leaps Forward: Meet MIT Technology Review’s Innovator of the Year
MIT Technology Review has named Sneha Goenka its innovator of the Year for 2025, recognizing her groundbreaking work in computational biology. Goenka’s innovations are the engine behind the world’s fastest whole-genome sequencing method,now capable of diagnosing genetic conditions in under eight hours. This is a monumental achievement with the potential to fundamentally transform medical care, offering faster diagnoses and more personalized treatments.
%7CSUBCLASS%7C&utm_content=%7CDATE:m-d-Y%7C“>Register Here
Other Key Developments:
1. CDC Vaccine Recommendations Under Review: The CDC’s Advisory Committee on Immunization Practices (ACIP) has voted against recommending the MMRV vaccine (measles, mumps, rubella, and varicella) for children under 4. A vote on hepatitis B vaccines for newborns is expected today. This decision is sparking debate among medical professionals and parents alike.CNN & The Atlantic ($) Meanwhile, allies of RFK Jr. are actively defending his stance on vaccines, further fueling the controversy.Politico
2. Russia Exploits US Political Tensions: Russia is actively leveraging recent events – including the shooting involving conservative commentator Charlie Kirk – to sow division within the United States. Pro-Kremlin narratives are gaining traction online, aiming to exacerbate existing political fractures. Washington Post ($) This highlights the ongoing threat of foreign interference in domestic affairs and the complexities of political violence. Vox It also raises questions about the meaning of being “terminally online” and its impact on our understanding of reality. Wired ($)
3. Nvidia and Intel Forge Strategic partnership: nvidia will invest $5 billion in Intel, a move that will allow Intel to develop custom CPUs optimized to work with Nvidia’s technology. This partnership signals a significant shift in the semiconductor landscape